BCH
NVO

Berkshire Capital Holdings’s Novo Nordisk NVO Stock Holding History

Berkshire Capital Holdings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10
Closed -$690 – 121
2025
Q2 		$690 Hold
10
– – ﹤0.01% 83
2025
Q1 		$694 Hold
10
– – ﹤0.01% 71
2024
Q4 		$860 Hold
10
– – ﹤0.01% 71
2024
Q3 		$1.19K Hold
10
– – ﹤0.01% 58
2024
Q2 		$1.43K Hold
10
– – ﹤0.01% 53
2024
Q1 		$1.28K Buy
+10
New +$1.19K ﹤0.01% 53

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Berkshire Capital Holdings's NVO Position: Q3 2025 in Review

Berkshire Capital Holdings sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 10 shares — an estimated $690 sold.

Berkshire Capital Holdings first reported a position in NVO in Q1 2024 and held it in 6 quarters. The position peaked at $1.43K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Berkshire Capital Holdings reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Berkshire Capital Holdings sold 10 Novo Nordisk shares in Q3 2025, an estimated $690.
  • Berkshire Capital Holdings first reported a position in Novo Nordisk in Q1 2024 and held it in 6 quarters.
  • Berkshire Capital Holdings's Novo Nordisk position peaked at $1.43K in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Berkshire Capital Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.